Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
553 participants
OBSERVATIONAL
2016-02-06
2019-01-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genetic Risk Estimations for Influencing Decision Making in Women at High Risk of Breast Cancer, GENRE 2 Study
NCT04474834
Comprehensive Genetic Assessment, Risk and Education in a Mammography Pilot
NCT04002986
Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women
NCT05755269
Clinical Implementation of a Polygenic Risk Score (PRS) for Breast Cancer
NCT03688204
Personalized Breast Cancer Screening
NCT06060938
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
History of invasive breast cancer
Subjects with a diagnosis of invasive breast cancer within the past 12 months will provide a blood or saliva sample for genetic diagnostic testing and provide information about their personal medical and cancer history and family cancer history.
Diagnostic test
Genetic diagnostic test
No history of invasive breast cancer
Subjects with no history of breast cancer will provide a blood or saliva sample for genetic diagnostic testing and provide information about their personal medical and cancer history and family cancer history.
Diagnostic test
Genetic diagnostic test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diagnostic test
Genetic diagnostic test
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 to 84 years of age
* Western/Northern European, Central/Eastern European, or Ashkenazi ancestry
* No history of invasive breast cancer
Women with a history of breast cancer:
* 18 to 84 years of age
* Western/Northern European, Central/Eastern European, or Ashkenazi ancestry
* Pathologically confirmed invasive breast cancer diagnosed within the past 12 months
Exclusion Criteria
* Women with history of ductal carcinoma in situ (DCIS).
* Patient has had a prior breast biopsy, exclusive of a breast biopsy diagnostic of breast cancer, that showed either hyperplasia, atypical hyperplasia, lobular carcinoma in situ (LCIS), or the specific histologic result is unknown to the patient
18 Years
84 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Myriad Genetic Laboratories, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John Holmsn, MD
Role: STUDY_DIRECTOR
Myriad Genetics, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Breast Center of Northwest Arkansas
Fayetteville, Arkansas, United States
Bethesda Health
Boynton Beach, Florida, United States
Cuda Women's Health Center
Hyannis, Massachusetts, United States
Elizabeth Wende Breast Care
Rochester, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HCP-018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.